Seroepidemiology of gastritis in Japanese and Dutch working populations: Evidence for the development of atrophic gastritis that is not related to Helicobacter pylori

Gut

Volumn 37, Issue 2, 1995, Pages 199-204

  Schlemper, R J ^a   Van Der Werf, S D J ^b   Vandenbroucke, J P ^a   Biemond, I ^a   Lamers, C B H W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

atrophic gastritis; epidemiology; gastric cancer; Helicobacter pylori; pepsinogen

Indexed keywords

GASTRIN; IMMUNOGLOBULIN G ANTIBODY; MARKER; PEPSINOGEN; PEPSINOGEN II;

ADULT; ANTIBODY DETECTION; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; SEROEPIDEMIOLOGY; STOMACH CANCER;

EID: 0029159847     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.37.2.199     Document Type: Article

References (44)

1. Samloff IM, Varis K, Ihamäki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982; 83: 204-9.
2. Borch K, Axelsson CK, Halgreen H, Damkjaer Nielsen M, Ledin T, et al. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol 1989; 24: 870-6.
3. Haruki K, Kurokawa K, Adachi H, Obata H. Serum and gastric mucosal pepsinogens in atrophic gastritis, particularly in type A gastritis associated with pernicious anemia in Japanese. Gastroenterol Jpn 1993; 28: 359-66.
4. Westerveld BD, Pals G, Lamers CBHW, Defize J, Pronk JC, Frants RR, et al. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer 1987; 59: 952-8.
5. Bins M, Burgers PICJ, Selbach SGM, van Wettum TB, Lamers CBHW, van Tongeren JHM. The relation between basal gastric pH and serum gastrin. Digestion 1982; 23: 271-3.
6. Varis K, Samloff IM, Ihamäki T, Siurala M. An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia. Dig Dis Sci 1979; 24: 187-91.
7. Karnes WE, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SWR, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991; 101: 167-74.
8. Ihamäki T, Varis K, Siurala M. Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families. Comparison with a computer-matched family sample. Scand J Gastroenterol 1979; 14: 801-12.
9. Ihamäki T, Saukkonen M, Siurala M. Long-term observation of subjects with normal mucosa and with superficial gastritis: results of 23-27 years' follow-up examinations. Scand J Gastroenterol 1978; 13: 771-5.
10. Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 1990; 50: 4737-40.
11. Ihamäki T, Kekki M, Sipponen P, Siurala M. The sequelae and course of chronic gastritis during a 30- to 34-year bioptic follow-up study. Scand J Gastroenterol 1985; 20: 485-91.
12. Walker IR, Strickland RG, Ungar B, Mackay IR. Simple atrophic gastritis and gastric carcinoma. Gut 1971; 12: 906-11.
13. Strickland RG, Mackay IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Dig Dis Sci 1973; 18: 426-40.
14. Imai T, Kubo T, Watanabe H. Chronic gastritis in Japanese with reference to high incidence of gastric carcinoma. J Natl Cancer Inst 1971; 47: 179-95.
15. Kato I, Tominaga S, Ito Y, Kobayashi S, Yoshii Y, Matsuura A, et al. A prospective study of atrophic gastritis and stomach cancer risk. Jpn J Cancer Res 1992; 83: 1137-42.
16. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 3554-60.
17. Correa P. Is gastric carcinoma an infectious disease? N Engl J Med 1991; 325: 1170-1.
18. Forman D, Newell DG, Fullerton F, Yarnell JWG, Stacey AR, Wald N, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991; 302: 1302-5.
19. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
20. Nomura A, Stemmermann GN, Chyou P-H, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132-6.
21. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, et al. Gastric carcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734-9.
22. Hansson L-E, Engstrand L, Nyrén O, Evans DJ, Lindgren A, Bergström R, et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993; 105: 1098-103.
23. Forman D, Webb P, Newell D, Coleman M, Palli D, Moller H, et al. An international association between Helicobacter pylori infection and gastric cancer. The Eurogast Study Group. Lancet 1993; 341: 1359-62.
24. Palli D, Decarli A, Cipriani F, Sitas F, Forman D, Amadori D, et al. Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk. Cancer Epidemiol Biomarkers Prev 1993; 2: 37-40.
25. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986; 8: 1-27.
26. Schlemper RJ, van der Werf SDJ, Vandenbroucke JP, Biemond I, Lamers CBHW. Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in the Netherlands and Japan. Scand J Gastroenterol 1993; 28 (suppl 200): 33-41.
27. Peña AS, Endtz HPh, Offerhaus GJA, Hoogenboom-Verdegaal A, van Duijn W, de Vargas N, et al. Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion 1989; 44: 131-41.
28. Veenendaal RA, Peña AS, Kuiper I, van Duijn W, Lamers CBHW. Diagnostic value of the local and systemic antibody response to Helicobacter pylori infection [Abstract]. Irish J Med Science 1992; 161 (suppl 10): 76-7.
29. Biemond I, Jansen JBMJ, Crobach LFSJ, Kreuning J, Lamers CBHW. Radioimmunoassay of human pepsinogen A and pepsinogen C. Eur J Clin Chem Clin Biochem 1989; 27: 19-25.
30. Biemond I, Kreuning J, Jansen JBMJ, Lamers CBHW. Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. Gut 1993; 34: 1315-8.
31. Biemond I, Kreuning J, Jansen JBMJ, Lamers CBHW. Serum pepsinogens in patients with gastric diseases or after gastric surgery. Scand J Gastroenterol 1994; 29: 238-42.
32. Jansen JBMJ, Lamers CBHW. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome. Gastroenterology 1982; 83: 173-8.
33. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992; 102: 760-6.
34. Kuipers EJ, Uyterlinde AM, Nelis GF, Meijer CJLM, Peña AS, Meuwissen SGM. Long term follow up of Helicobacter pylori associated gastritis [Abstract]. Gastroenterology 1994; 106: A113.
35. Nomura A, Yamakawa H, Ishidate T, Kamiyama S, Masuda H, Stemmermann GN, et al. Intestinal metaplasia in Japan: association with diet. J Natl Cancer Inst 1982; 68: 401-5.
36. Villako K, Maards H, Tammur R, Keevalik R, Peetsala M, Sipponen P, et al. Helicobacter (Campylobacter) pylori infestation and the development and progression of chronic gastritis: results of long-term follow-up examinations of a random sample. Endoscopy 1990; 22: 114-7.
37. Satoh K, Kimura K, Yoshida Y, Taniguchi Y, Kasano T, Kihira K, et al. Helicobacter pylori infection and the extension of atrophic gastritis. European Journal of Gastroenterology and Hepatology 1993; 5 (suppl 1): S115-7.
38. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968; 40: 43-68.
39. Kohli Y, Pfeiffer CJ, Kutty KP, Barrowman JA, Heughan C, Kepkay DL. Endoscopic diagnosis of intestinal metaplasia in Canada and Japan. J Clin Gastroenterol 1981; 3 (suppl 1): 29-33.
40. Kimura K. Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972; 63: 584-92.
41. Villako K, Kekki M, Tamm A, Tammur R, Savisaar E, Viirsalu V, et al. Epidemiology and dynamics of gastritis in a representative sample of an Estonian urban population. Scand J Gastroenterol 1982; 17: 601-7.
42. Cheli R, Simon L, Aste H, Figus IA, Nicoló G, Bajtai A, et al. Atrophic gastritis and intestinal metaplasia in asymptomatic Hungarian and Italian populations. Endoscopy 1980; 12: 105-8.
43. Mossi S, Meyer-Wyss B, Renner EL, Merki HS, Gamboni G, Berglinger C. Influence of Helicobacter pylori, sex, and age on serum gastrin and pepsinogen concentrations in subjects without symptoms and patients with duodenal ulcers. Gut 1993; 34: 752-6.
44. Waldum HL, Petersen H, Brenna E. Gastrin and gastric cancer. European Journal of Gastroenterology and Hepatology 1992; 4: 801-11.